By John Kahn, Partner, CFGI You may have heard about the massive spike in the popularity of SPACs, but have you heard about Zombie SPACs and Blood Baths? Writing this in Atlanta, Georgia, home of “The Walking Dead” TV show, makes it easier to appreciate that a “Zombie SPAC” is a SPAC without enough life… More
CFGI’s Life Sciences team assisted Third Harmonic Bio (NASDAQ: THRD) with their initial public offering.
CFGI’s Capital Markets team assisted Senti Biosciences, Incorporated (“Senti Bio”) with the completion of its merger with Dynamics Special Purpose Corporation (“DYNS”) (Nasdaq: DYNS), a special purpose acquisition company.
CFGI’s Capital Markets team assisted privately-owned BCP Raptor Holdco LP (“BCP”), the parent company of EagleClaw Midstream, with the completion of an all-stock business combination with Altus Midstream Company (Nasdaq: ALTM) (“Altus”), creating a unique, fully-integrated midstream company.
2021 was an exciting year of growth for CFGI, which included a new partnership with CVC Capital Partners, one of the world’s largest private equity firms.
CFGI’s Capital Markets team assisted Enjoy Technology, Inc.
The Securities and Exchange Commission (SEC) recently adopted new amendments as part of an ongoing effort to “modernize and enhance” regulations related to financial disclosures as well as management’s discussion and analysis (MD&A).
CFGI’s Capital Markets team supported atai Life Sciences B.